European Association of Urology (EAU) guidelines

do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group

Alberto Briganti, Steven MacLennan, Lorenzo Marconi, Karin Plass, James N'Dow, EAU Guidelines Office ‘IMAGINE’ project

Research output: Contribution to journalEditorial

125 Citations (Scopus)

Abstract

There is increasing evidence in the literature that androgen deprivation therapy (ADT) is overused among practising urologists in the setting of localized, and even locally advanced, prostate cancer (PCa). Morgia et al. report a misuse of ADT prescriptions among Italian urologists in roughly a quarter of cases, mainly in the setting of low-risk/localized disease where ADT may harm patients without proven benefit with regard to disease-specific outcomes. Such clinical practice behaviours are even more unjustifiable given the high level of evidence upon which the current European Association of Urology (EAU) guidelines recommendations on ADT use are based.
Original languageEnglish
Pages (from-to)850-851
Number of pages2
JournalBJU International
Volume117
Issue number6
Early online date13 May 2016
DOIs
Publication statusPublished - Jun 2016

Fingerprint

Urology
Androgens
Guidelines
Education
Patient Harm
Therapeutics
Prescriptions
Prostatic Neoplasms
Urologists

Cite this

European Association of Urology (EAU) guidelines : do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group. / Briganti, Alberto; MacLennan, Steven; Marconi, Lorenzo; Plass, Karin; N'Dow, James; EAU Guidelines Office ‘IMAGINE’ project.

In: BJU International, Vol. 117, No. 6, 06.2016, p. 850-851.

Research output: Contribution to journalEditorial

Briganti, Alberto ; MacLennan, Steven ; Marconi, Lorenzo ; Plass, Karin ; N'Dow, James ; EAU Guidelines Office ‘IMAGINE’ project. / European Association of Urology (EAU) guidelines : do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group. In: BJU International. 2016 ; Vol. 117, No. 6. pp. 850-851.
@article{21aaf8d5412f4dd5b168879057b4d342,
title = "European Association of Urology (EAU) guidelines: do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group",
abstract = "There is increasing evidence in the literature that androgen deprivation therapy (ADT) is overused among practising urologists in the setting of localized, and even locally advanced, prostate cancer (PCa). Morgia et al. report a misuse of ADT prescriptions among Italian urologists in roughly a quarter of cases, mainly in the setting of low-risk/localized disease where ADT may harm patients without proven benefit with regard to disease-specific outcomes. Such clinical practice behaviours are even more unjustifiable given the high level of evidence upon which the current European Association of Urology (EAU) guidelines recommendations on ADT use are based.",
author = "Alberto Briganti and Steven MacLennan and Lorenzo Marconi and Karin Plass and James N'Dow and {EAU Guidelines Office ‘IMAGINE’ project}",
year = "2016",
month = "6",
doi = "10.1111/bju.13383",
language = "English",
volume = "117",
pages = "850--851",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - European Association of Urology (EAU) guidelines

T2 - do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group

AU - Briganti, Alberto

AU - MacLennan, Steven

AU - Marconi, Lorenzo

AU - Plass, Karin

AU - N'Dow, James

AU - EAU Guidelines Office ‘IMAGINE’ project

PY - 2016/6

Y1 - 2016/6

N2 - There is increasing evidence in the literature that androgen deprivation therapy (ADT) is overused among practising urologists in the setting of localized, and even locally advanced, prostate cancer (PCa). Morgia et al. report a misuse of ADT prescriptions among Italian urologists in roughly a quarter of cases, mainly in the setting of low-risk/localized disease where ADT may harm patients without proven benefit with regard to disease-specific outcomes. Such clinical practice behaviours are even more unjustifiable given the high level of evidence upon which the current European Association of Urology (EAU) guidelines recommendations on ADT use are based.

AB - There is increasing evidence in the literature that androgen deprivation therapy (ADT) is overused among practising urologists in the setting of localized, and even locally advanced, prostate cancer (PCa). Morgia et al. report a misuse of ADT prescriptions among Italian urologists in roughly a quarter of cases, mainly in the setting of low-risk/localized disease where ADT may harm patients without proven benefit with regard to disease-specific outcomes. Such clinical practice behaviours are even more unjustifiable given the high level of evidence upon which the current European Association of Urology (EAU) guidelines recommendations on ADT use are based.

U2 - 10.1111/bju.13383

DO - 10.1111/bju.13383

M3 - Editorial

VL - 117

SP - 850

EP - 851

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 6

ER -